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Abstract 
Urinary tract infections (UTIs) are known as one of the most important infections around the world, 
and Escherichia coli is the most important cause of UTI. Also, the empiric treatment and misusing of 
antimicrobial agents has led to increasing multi-drug resistance around the world which is a worldwide 
concern. Extended-spectrum beta-lactamase (ESBLs) is an enzyme group that is produced by the 
Enterobacteriaceae family. The three main ESBLs enzyme are as follow: blaCTX-M, blaTEM, and blaSHV, 
additionally, there are several types of each of them by the same mechanism. This study was conducted 
to evaluate the prevalence of ESBL genes among E. coli isolated from UTI patients. A total of 105 isolates 
were collected from UTI patients at two hospitals in Mashhad from 2017 to 2019. Bacterial 
identification was performed by standard microbiologic methods. The assessment of antimicrobial 
susceptibility was accomplished by the disk diffusion method. The presence of ESBL genes was 
investigated by multiplex-PCR. The prevalence of UTI, among females, was identified more than males. 
Furthermore, the blaTEM and blaCTX-M genes were detected in all isolates, but only six isolates (5.7%) 
were harboring blaSHV. The considerable role of E. coli in UTI infection, as well as the presence of ESBL 
genes in E. coli strains, emphasize the need for surveillance of antimicrobial therapy to prevent the 
extension of resistance among clinical strains. 
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1. Introduction 
Urinary tract infections (UTIs) happen through 
community-acquired or nosocomial-acquired, which 
are one of the most prevalent types of human infection 
[1, 2]. Escherichia coli is known as the most important 
pathogen in UTIs, among both outpatient and 
inpatient [3, 4]. On the other hand, the empiric of 
treatment and misusing of antimicrobial agents such 
as, beta-lactams, beta-lactamase inhibitor, 
fluoroquinolones, and carbapenems, has led to 
increasing multi-drug resistance around the world 
which is a worldwide concern [5, 6]. Extended-
spectrum beta-lactamase (ESBLs) is an enzyme group 
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that is produced by the Enterobacteriaceae family, 
which are mostly isolated from inpatient cases [7]. The 
ESBL positive bacteria are able to inactivate several 
antimicrobial agents including an oxyimino-group 
such as cephalosporins (e.g. ceftazidime, and 
ceftriaxone), monobactam (e.g. aztreonam), but not 
able to inactivate cephamycin, and carbapenems [7, 
8]. The three main ESBL enzymes are blaCTX-M, blaTEM, 
and blaSHV [9, 10]. These enzymes are encoded 
generally by genes located on plasmids. Actually, the 
mutation in these genes (particularly blaTEM and 
blaSHV) led to the change in the form of the enzyme 
near its active site to increment the affinity and 
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hydrolytic capability of beta-lactamase for oxyimino 
compounds [11]. Also, some of them are encoding on 
transposons which could transmit between organisms 
[8]. The growing up of ESBL producing strains brings 
up some problems including the transmission of 
resistance to other organisms, refusing treatment, and 
increase in mortality rate. So, more surveillance is 
needed to identify the rate of the problem and help to 
select appropriate antimicrobial agents to treat the 
infection. This study was conducted to evaluate the 
prevalence of blaTEM, blaCTX-M, and blaSHV genes by 
multiplex polymerase chain reaction (M-PCR) among 
E. coli isolated from UTI patients.  
2. Materials and Methods 
2.1 Sample’s collection 
A total of 105 E. coli isolates were collected from 
UTI patients at Ghaem and Emamreza hospitals in 
Mashhad from 2017 to 2019. Also, the basic 
information of patients was gathered, including age 
and gender, UTI history, hospital visit reports, and 
reports of taken antimicrobial agents from patients. 
Isolates cultured on selective-differential media, 
MacConkey agar (MAC), and Eosin Methylene Blue 
agar (EMB), were incubated overnight at 37°C. Then, 
microscopically examination was done by Gram 
staining from lactose-positive colonies. Likewise, 
biochemical profiling, such as Oxidase/Catalase 
activity, Motility, Indole, Urease, Triple Sugar Iron 
agar (TSI), and Methyl Red-Voges Proskauer test 
(MR-VP) has been studied. 
 
2.2 Antimicrobial susceptibility test 
The assessment of antimicrobial susceptibility was 
accomplished by the disk diffusion method 
recommended by the Clinical and Laboratory 
Standards Institute (CLSI, 2020) (13)[12],  against 15 
antibiotic disks (Padtanteb, Iran) as follow:  
ceftazidime (30 μg), imipenem (10 μg), amikacin (30 
μg), nalidixic acid (30 μg), ampicillin (10 μg), 
ciprofloxacin (5 μg), cefixime (5 μg), cefazoline (30 μg), 
ceftriaxone (30 μg), meropenem (10 μg), gentamicin 
(10 μg), nitrofurantoin (300 μg), cefepime (30 μg), 
cefotaxime (30 μg) and co-trimoxazole (1.25/23.75 
μg). E. coli ATCC 25922 was used as a positive control 
for antimicrobial susceptibility tests. 
 
2.3 PCR amplification 
DNA extraction was done by the boiling method 
as described earlier by Nazari et al. [13]. The prepared 
DNA samples were assessed for prevalence of blaTEM, 
blaSHV, and blaCTX-M genes by M-PCR by using the MJ 
mini thermal cycler (Bio-Rad, Hercules, CA, USA) 
[14]. The PCR reaction was conducted in 25 volumes 
including 12.5 μl of PCR 2X MasterMix (Parstous 
company, Iran) containing Taq DNA Polymerase, 
reaction buffer, dNTPs mixture, a protein stabilizer, 
and the convenience for use was optimized by adding 
Table 1. The information of oligonucleotides used as primer in multiplex-PCR 
 
Primer name Primer sequence (5’-3’) Amplicon size (bp) Reference 
blaTEM164.SE TCG CCG CAT ACA CTA TTC TCA GAA TGA 
445 
14 
blaTEM164.AS ACG CTC ACC GGC TCC AGA TTT AT 
blaSHV.SE ATG CGT TAT ATT CGC CTG TG 
724 
blaSHV.AS TGC TTT GTT ATT CGG GCC AA 
blaCTX-M. U1 ATG TGC AGC ACC AGT AAA GTG ATG GC 
593 
blaCTX-M. U2 TGG GTA AAG TAA GTG ACC AGA ATC AGC GG 
 
Table 2. The frequency of UTI in different age groups  
 
Age groups <10 11-20 21-30 31-40 41-50 51-60 >60 
Female 8 3 9 5 5 10 16 
Male 5 0 2 3 6 5 28 
Total a 13 3 11 8 11 15 44 
 
a Results presented as number of cases 
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sediment for electrophoresis and 2x solution of 
loading dye, 1 μl of each primer (10 pM), 2 μl of DNA 
template (100 ng/reaction) and 4.5 μl of Nuclease-free 
water. PCR conditions were as follow: initial 
denaturation at 95°C for 15 seconds; followed by 35 
cycles of denaturation at 94°C for 30 seconds, 
annealing at 61°C for 40 seconds, and extension at 
72°C for 2 minutes with a final extension at 72°C for 10 
minutes [15]. Electrophoresis of amplicons was 
performed using 1.5% agarose gels. The primers' 
information is listed in Table 1. Also, E. coli ATCC 
35218 and distilled water were used as the positive and 
negative control, respectively. 
 
3. Results  
3.1 Prevalence of UTI in different ages and 
genders 
Based on the results, it was determined that the 
prevalence of UTI among females with 56 (53.3%) 
cases was more than males with 49 (46.7%) cases. 
Most isolates were recovered from patients with >60 
ages, and the lowest rate was observed in 11-20 age 
groups. The information of patients’ age groups was 
listed in Table 2. 
 
3.2 Antimicrobial susceptibility test 
According to the results, amikacin (98%), 
meropenem (93%), nitrofurantoin (89%), and 
imipenem (88%) revealed the highest activity against 
isolates, respectively. All results are listed in Table 3. 
 
3.3 PCR results 
The analysis of PCR products on gel 
electrophoresis revealed that the most prevalent 
ESBLs among studied isolates were blaTEM, and blaCTX-
M genes (100%). While only six (5.71%) isolates were 
carried the blaSHV gene. 
 
4. Discussion  
UTI is known as one of the most highlighted 
healthcare infections. Our finding notes that women 
have a higher rate of UTI than men. This fact confirms 
earlier findings of the stress UTI in females [16-19]. 
Also, the most prevalent was observed in the >60 age 
group, which was similar to previous surveys [20, 21]. 
However, this result was in contrast with other 
observations, which reported the highest prevalence in 
2-10 and 20-29 age groups, respectively [17, 22]. Our 
results revealed the highest resistance rate for 
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ampicillin (82.8%) and cotrimoxazole (70.4%) which 
was consistent whit previous surveys [17, 23-25]. 
However, another study was recorded a lower 
resistance rate for ampicillin and cotrimoxazole, 67% 
and 45%, respectively [26]. On the other hand, the 
highest susceptibility was observed against amikacin, 
meropenem, nitrofurantoin, and imipenem. While the 
lower susceptibility for amikacin (61%) and 
nitrofurantoin (72%) has been reported in an earlier 
survey [27]. However, our finding for nitrofurantoin 
susceptibility was close to other studies [17, 28]. Also, 
the susceptibility rate of isolates to imipenem and 
amikacin in the current study was in line with previous 
surveys [17, 23, 29]. 
According to earlier reports, the high rate of ESBL-
E. coli was noted from UTI among both inpatient and 
outpatient, whereas it was more significant among 
inpatient [24, 30]. 
Generally, the highest presence of ESBLs was 
recorded for blaTEM and blaCTX-M, which was in line 
with earlier results [9, 31-34]. Although, some studies 
reported a lower rate of blaCTX-M, 28%, and 32%, 
respectively [35, 36]. This discrepancy can be 
explained by different geography and the increase of 
genes transferring during the time. On the other hand, 
blaSHV was detected in only six isolates. Our 
experiment about the prevalence of the blaSHV gene 
was close to previous survey [33]. According to these 
results, the blaSHV gene is not predominant as the two 
other genes. However, new studies revealed a high 
frequency of blaSHV that might increase in the future 
[11, 37]. Certainly, further tests such as confirmatory 
ESBL test and statistical analysis are required to 
determine the relationship between these genes and 
resistant phenotype.  
The considerable role of E. coli in UTI infection, as 
well as the presence of ESBL genes in E. coli strains, 
emphasize the need for surveillance of antimicrobial 
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